AwardTape · Defense awards · Research and development · Health R&D · W81XWH21C0121
W81XWH21C0121: -$99K definitive contract to Mapp Biopharmaceutical, Inc
Mapp Biopharmaceutical, Inc holds a definitive contract from Defense Health Agency with -$99K obligated since Oct 2023 and $601K obligated over its life, against a ceiling of $1.2M. Latest action Jul 31, 2024.
Base year for macv contract generates macv igg2
| PIID | W81XWH21C0121 |
|---|---|
| Type | definitive contract |
| Company | Mapp Biopharmaceutical, Inc |
| Agency | Defense Health Agency |
| Contracting office | ARMY MED RES ACQ ACTIVITY |
| Category | Research and development · Health R&D |
| PSC | AN13 HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT |
| NAICS | 541380 TESTING LABORATORIES AND SERVICES |
| Obligated since Oct 2023 | -$99K |
| Total obligated (lifetime) | $601K |
| Ceiling (base and all options) | $1.2M |
| Base date | Sep 30, 2021 |
| Latest action | Jul 31, 2024 |
| End date | Mar 1, 2025 |
| Actions since Oct 2023 | 2 |
| Pricing | Firm fixed price |
| Competition | Full and open competition |
| Place of performance | MD |
| Source | USAspending.gov record |
| Reporting lag | DoD 90 days |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Place of performance shows the state only.
Terminal: alerts on new orders and modifications to this contract, and CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial